Silver Book Fact

The cost-effectiveness of detection and treatment of eye disease in diabetics is $3,190 per quality adjusted life year (QALY).

Javitt, Jonathan C., and Lloyd Paul Aiello. Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy. Annals of Internal Medicine. 1996; 124(1): 164-9. http://www.annals.org/cgi/content/abstract/124/1_Part_2/164

Reference

Title
Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy
Publication
Annals of Internal Medicine
Publication Date
1996
Authors
Javitt, Jonathan C., and Lloyd Paul Aiello
Volume & Issue
Volume 124, Issue 1
Pages
164-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Treatment costs for a patient with early-stage glaucoma are about $2,000 less than those of a patient diagnosed with a later stage of the disease.  
  • Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.  
  • Mobile Exam for DR
    Use of a mobile examination for DR screening in Finland decreased visual impairment by 86% in the covered area.  
  • The use of antioxidant vitamins and other new therapies for age-related macular degeneration (AMD) could reduce visual impairment and blindness from the disease by 35%.  
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of over $472.1 million– in 1994 dollars.